Vaccine Based on Spider Silk

News   Jun 13, 2018 | Original story from the University of Geneva (UNIGE)

 
Vaccine Based on Spider Silk

Immune cells that ingested spider silk nanoparticles (in green). The endosomes - the part of the cell in which the nanoparticles release the vaccine - appear in blue. Credit: © Laboratoire Bourquin - UNIGE

 
 
 

RELATED ARTICLES

New Ovarian Cancer Target

News

Researchers have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. This new study opens a potential avenue for treating ovarian cancer. Since Calcitriol is an FDA-approved drug, no additional research is needed before the drug can advance to human clinical trials for ovarian cancer.

READ MORE

Recruiting Microbes to Combat Cholera Infection

News

MIT engineers have developed a probiotic mix of natural and engineered bacteria to diagnose and treat cholera, an intestinal infection that causes severe dehydration.

READ MORE

Sartorius Stedim Biotech and Siemens Sign Automation Agreement

News

Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy